For many people diagnosed with cancer, treatment with immune checkpoint inhibitors (ICIs) has dramatically extended lives. Some of these treatments, such as Keytruda and Opdivo, have become familiar brand names. However, for some patients, ICI…
Continue Reading
News Source: medicalxpress.com
Leave a Reply